Evaluation of the clinical practice of Informed Consent in clinical trials

Authors

  • J. Gost
  • C. Silvestre
  • P. Ezpeleta
  • P. Astier
  • O. Díaz de Rada
  • M.T. Artázcoz

DOI:

https://doi.org/10.23938/ASSN.0461

Keywords:

Ensayos clínicos con medicamentos. Consentimiento Informado. Legibilidad. Declaración de Helsinki. Comité Ético de Investigación Clínica.

Abstract

On the basis of existing publications it would seem legitimate to assume that in a clinical test (CT) the difficulties inherent in the process of researcher-participant communication are in practice greater than desired. Similarly, the hypothesis is adopted that difficulties exist in the formal legibility of the documents of Informed Consent. We present the results of a transversal study made of a random sample (n=160) of the CTs approved by the Ethical Committee of Clinical Research (CEIC) of Navarra during the years 1995-1999. The results found were: in 69.7% of the cases the researcher filed the documents corresponding to the CT, the Informed Consent appears signed by the researcher in 56.6% of the CTs, and in more than 83% of the cases the written information shows shortcomings in legibility, which confirms the correctness of the hypothesis and permits the detection of areas where improvements need to be developed.

Downloads

Download data is not yet available.

Published

2009-01-09

How to Cite

1.
Gost J, Silvestre C, Ezpeleta P, Astier P, Díaz de Rada O, Artázcoz M. Evaluation of the clinical practice of Informed Consent in clinical trials. An Sist Sanit Navar [Internet]. 2009 Jan. 9 [cited 2025 Dec. 14];26(1):35-42. Available from: https://recyt.fecyt.es/index.php/ASSN/article/view/5135

Issue

Section

Research articles

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.